Excedrin 250 mg /250 mg /65 mg film-coated tablets
*Company:
Haleon Ireland LimitedStatus:
UpdatedLegal Category:
Supply through pharmacy onlyActive Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 27 November 2024
File name
Master-ie-text-PIL-excedrin-clean-RFI-PT name change-240820SKDJ.pdf
Reasons for updating
- Change to other sources of information section
Free text change information supplied by the pharmaceutical company
Change to PT name
Updated on 03 September 2024
File name
Approved excedrin leafelt 27 September 2024.pdf
Reasons for updating
- Change to further information section
Free text change information supplied by the pharmaceutical company
Change to Luxemburg and Belgium name
Updated on 10 July 2024
File name
MASTER-ie-text-PIL-excedrin-clean-approved-08Jul2024.pdf
Reasons for updating
- Change to section 2 - pregnancy, breast feeding and fertility
- Change to section 6 - date of revision
Updated on 09 July 2024
File name
MASTER-ie-spc-excedrin-clean-approved-08Jul2024.pdf
Reasons for updating
- Change to section 4.6 - Pregnancy and lactation
- Change to section 10 - Date of revision of the text
Legal category:Supply through pharmacy only
Updated on 09 July 2024
File name
MASTER-ie-mockup-PIL-excedrin-clean-approved-08Jul2024.pdf
Reasons for updating
- Change to section 2 - interactions with other medicines, food or drink
- Change to section 2 - pregnancy, breast feeding and fertility
- Change to section 6 - date of revision
Updated on 25 April 2023
File name
ie-working-spc-excedrin-typeIAIN-Separation-clean-230208SKDJ.pdf
Reasons for updating
- Change to section 7 - Marketing authorisation holder
Legal category:Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
Update to MAH name
Updated on 25 April 2023
File name
ie-pl-excedrin-Haleon Name change-implemented 3 March 2023.pdf
Reasons for updating
- Change to section 6 - marketing authorisation holder
Free text change information supplied by the pharmaceutical company
Update to MAH name
Updated on 18 January 2023
File name
ie-working-PIL-excedrin-Type IB-PRAC update-Flucloxacillin-approved 12-01-23 (003).pdf
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
Updated on 18 January 2023
File name
ie-working-spc-excedrin-typeIB-PRAC update-Flucloxacillin-approved 12-01-23 (004).pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
Legal category:Supply through pharmacy only
Updated on 18 January 2023
File name
ie-working-spc-excedrin-typeIA-CRSF-220907SKDJ-clean.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
Legal category:Supply through pharmacy only
Updated on 29 September 2022
File name
ie-working-spc-excedrin-typeIA-CRSF-220907SKDJ-clean.pdf
Reasons for updating
- Change to section 6.5 - Nature and contents of container
Legal category:Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
Addition of CRSF blister packaging.
Updated on 04 September 2020
File name
ie-pl-excedrin-safety update - II-043-G approved 4th Sept 2020.pdf
Reasons for updating
- Change to section 2 - what you need to know - contraindications
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 2 - pregnancy, breast feeding and fertility
- Change to section 3 - dose and frequency
- Change to section 3 - overdose, missed or forgotten doses
- Change to section 4 - possible side effects
Updated on 04 September 2020
File name
ie-spc-excedrin-safety update- II-43-G approved 4th Sept 2020.pdf
Reasons for updating
- Change to section 4.2 - Posology and method of administration
- Change to section 4.3 - Contraindications
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.6 - Pregnancy and lactation
- Change to Section 4.8 – Undesirable effects - how to report a side effect
- Change to section 4.9 - Overdose
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 5.2 - Pharmacokinetic properties
- Change to section 5.3 - Preclinical safety data
- Change to section 6.6 - Special precautions for disposal and other handling
Legal category:Supply through pharmacy only
Updated on 28 March 2019
File name
ie-mockup-pl-61(3)Famar-190204EM.pdf
Reasons for updating
- Change to section 6 - manufacturer
Updated on 04 January 2019
File name
ie-spc-excedrin-proposed-clean-dec2018-medie.pdf
Reasons for updating
- Change to section 6.5 - Nature and contents of container
- Change to section 10 - Date of revision of the text
Legal category:Supply through pharmacy only
Updated on 04 January 2019
File name
ie-spc-excedrin-proposed-clean-dec2018-medie.pdf
Reasons for updating
- New SPC for new product
Legal category:Supply through pharmacy only
Updated on 06 June 2017
File name
PIL_16707_876.pdf
Reasons for updating
- New PIL for new product
Updated on 06 June 2017
Reasons for updating
- Change to section 6 - date of revision
- Change to name of medicinal product
Updated on 03 May 2016
Reasons for updating
- New PIL for medicines.ie